If EAA Test Versus LAL Test is Always Clinically Better and Whether Any Test Always Relates to the Therapeutic Value of Hemoperfusion in Septic Shock Patients?
Shock
.
2023 Nov 1;60(5):725-726.
doi: 10.1097/SHK.0000000000002201.
Epub 2023 Aug 7.
Authors
Vladimir M Pisarev
,
Sergei I Rey
,
Vladimir V Kulabukhov
,
Alexander Yu Popov
PMID:
37549019
DOI:
10.1097/SHK.0000000000002201
No abstract available
MeSH terms
Anti-Bacterial Agents / therapeutic use
Hemoperfusion*
Humans
Polymyxin B / therapeutic use
Shock, Septic* / drug therapy
Shock, Septic* / therapy
Substances
Anti-Bacterial Agents
Polymyxin B